应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01061 亿胜生物科技
未开盘 08-05 16:08:59
2.365
-0.040
-1.66%
最高
2.410
最低
2.330
成交量
51.40万
今开
2.410
昨收
2.405
日振幅
3.33%
总市值
13.39亿
流通市值
13.39亿
总股本
5.66亿
成交额
122.21万
换手率
0.09%
流通股本
5.66亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
亿胜生物科技中期盈利1.107亿港元,每股派息5港仙
投资观察 · 08-05 19:36
亿胜生物科技中期盈利1.107亿港元,每股派息5港仙
亿胜生物科技2026年中期营收7.85亿港元 净利1.11亿港元
公告速递 · 08-05 19:31
亿胜生物科技2026年中期营收7.85亿港元 净利1.11亿港元
亿胜生物科技(01061)宣布派发2026年中期股息 每股0.05港元
公告速递 · 08-05 19:31
亿胜生物科技(01061)宣布派发2026年中期股息 每股0.05港元
亿胜生物科技(01061)公布中期业绩 溢利约1.11亿港元 同比减少32.2%
智通财经 · 08-05 19:29
亿胜生物科技(01061)公布中期业绩 溢利约1.11亿港元 同比减少32.2%
亿胜生物科技(01061)将于9月2日派发中期股息每股0.05港元
智通财经网 · 08-05 19:28
亿胜生物科技(01061)将于9月2日派发中期股息每股0.05港元
亿胜生物科技2026年7月股份变动月报:回购350,000股并转为库存股
公告速递 · 08-03 16:49
亿胜生物科技2026年7月股份变动月报:回购350,000股并转为库存股
亿胜生物科技(01061)8月5日举行董事会审议2026年中期业绩及派息事宜
公告速递 · 07-24
亿胜生物科技(01061)8月5日举行董事会审议2026年中期业绩及派息事宜
港股异动 | 亿胜生物科技(01061.HK)盈警后跌近13% 预期中期溢利同比减少约30%
智通财经 · 07-20
港股异动 | 亿胜生物科技(01061.HK)盈警后跌近13% 预期中期溢利同比减少约30%
港股异动 | 亿胜生物科技(01061)盈警后跌近13% 预期中期溢利同比减少约30%
智通财经 · 07-20
港股异动 | 亿胜生物科技(01061)盈警后跌近13% 预期中期溢利同比减少约30%
亿胜生物科技(01061)发盈警 预期中期溢利同比减少约30%
智通财经网 · 07-17
亿胜生物科技(01061)发盈警 预期中期溢利同比减少约30%
亿胜生物科技(01061.HK)发盈利警告:上半年利润或同比降约30%
公告速递 · 07-17
亿胜生物科技(01061.HK)发盈利警告:上半年利润或同比降约30%
亿胜生物科技回购35.00万股股份,总额约89.55万港元
公告速递 · 07-02
亿胜生物科技回购35.00万股股份,总额约89.55万港元
亿胜生物科技(01061)7月2日斥资89.55万港元回购35万股
智通财经 · 07-02
亿胜生物科技(01061)7月2日斥资89.55万港元回购35万股
亿胜生物科技更新2026年6月股份变动月报表,股本维持稳定
公告速递 · 07-02
亿胜生物科技更新2026年6月股份变动月报表,股本维持稳定
亿胜生物科技回购27.3万股,总额约72.52万港元
公告速递 · 06-30
亿胜生物科技回购27.3万股,总额约72.52万港元
亿胜生物科技:6月29日回购1万股股份,耗资约2.71万港元
公告速递 · 06-29
亿胜生物科技:6月29日回购1万股股份,耗资约2.71万港元
亿胜生物科技(01061)6月29日斥资约2.71万港元回购1万股
智通财经 · 06-29
亿胜生物科技(01061)6月29日斥资约2.71万港元回购1万股
亿胜生物科技6月26日回购5.00万股,涉资约13.50万港元
公告速递 · 06-26
亿胜生物科技6月26日回购5.00万股,涉资约13.50万港元
亿胜生物科技(01061)6月26日斥资约13.5万港元回购5万股
智通财经 · 06-26
亿胜生物科技(01061)6月26日斥资约13.5万港元回购5万股
亿胜生物科技:6月25日回购10万股,耗资约26.35万港元
公告速递 · 06-25
亿胜生物科技:6月25日回购10万股,耗资约26.35万港元
加载更多
公司概况
公司名称:
亿胜生物科技
所属市场:
SEHK
上市日期:
--
主营业务:
亿胜生物科技有限公司是一家主要从事生产及销售治疗体表创伤和眼部损伤生物药品的投资控股公司。该公司通过三个业务分部进行运营。外科分部主要从事开发、制造及销售贝复济液体制剂、贝复济冻干粉及贝复新凝胶以及其他产品。眼科分部从事开发、制造与销售贝复舒滴眼液、贝复舒眼用凝胶及贝复舒单剂量滴眼液以及其他产品。提供服务分部主要从事提供医疗科技电子平台相关医疗服务。
发行价格:
--
{"stockData":{"symbol":"01061","market":"HK","secType":"STK","nameCN":"亿胜生物科技","latestPrice":2.365,"timestamp":1785917339760,"preClose":2.405,"halted":0,"volume":514000,"delay":0,"changeRate":-0.016632016632016463,"floatShares":566000000,"shares":566000000,"eps":0.561,"marketStatus":"未开盘","change":-0.04,"latestTime":"08-05 16:08:59","open":2.41,"high":2.41,"low":2.33,"amount":1222145,"amplitude":0.033264,"askPrice":2.395,"askSize":15000,"bidPrice":2.365,"bidSize":44000,"shortable":0,"etf":0,"ttmEps":0.561,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785979800000},"marketStatusCode":0,"adr":0,"listingDate":993571200000,"exchange":"SEHK","adjPreClose":2.405,"dividendRate":0.059197,"openAndCloseTimeList":[[1785893400000,1785902400000],[1785906000000,1785916800000]],"volumeRatio":0.9661654136064786,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01061","defaultTab":"news","newsList":[{"id":"1133517581","title":"亿胜生物科技中期盈利1.107亿港元,每股派息5港仙","url":"https://stock-news.laohu8.com/highlight/detail?id=1133517581","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133517581?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:36","pubTimestamp":1785929798,"startTime":"0","endTime":"0","summary":"亿胜生物科技(ESSEX BIO-TECH)发布中期业绩,录得净利润1.107亿港元。公司宣布派发中期股息,每股0.05港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171725807","title":"亿胜生物科技2026年中期营收7.85亿港元 净利1.11亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171725807","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171725807?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:31","pubTimestamp":1785929490,"startTime":"0","endTime":"0","summary":"亿胜生物科技有限公司8月5日公布,截至2026年6月30日止六个月,公司实现营业额7.85亿港元,同比下降10.5%;期内溢利1.11亿港元,同比下降32.2%。报告期内,毛利率由88.8%降至83.6%;净利率由18.6%降至14.1%。外科业务实现收入3.41亿港元,上年同期为4.49亿港元;报告期内,公司斥资265.98万港元回购1,006,000股股份,并全部保留为库藏股份。截至报告期末,公司现金及未动用银行融资额度可满足已订立的1.70亿港元资本承诺及日常运营需求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168245558","title":"亿胜生物科技(01061)宣布派发2026年中期股息 每股0.05港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168245558","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168245558?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:31","pubTimestamp":1785929467,"startTime":"0","endTime":"0","summary":"亿胜生物科技有限公司(01061)8月5日发布公告称,董事会已决议就截至2026年6月30日止六个月派发中期股息,每股0.05港元,股息性质为普通股息。派息货币为港元,适用汇率为1港元兑1港元。公司不适用代扣所得税安排。 \n \n根据时间表,本次股息的除净日为2026年8月18日;股东欲登记获得股息,其股份过户文件须于2026年8月19日16时30分前递交香港中央证券登记有限公司。公司股份登记册将于2026年8月20日至2026年8月24日期间暂停办理过户手续,记录日期为2026年8月24日。股息派发日定于2026年9月2日。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657654914","title":"亿胜生物科技(01061)公布中期业绩 溢利约1.11亿港元 同比减少32.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657654914","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657654914?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:29","pubTimestamp":1785929393,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿胜生物科技 公布2026年中期业绩,营业额约7.85亿港元,同比减少10.5%;溢利约1.11亿港元,同比减少32.2%;每股盈利19.53港仙,拟派每股中期股息5港仙。公告称,营业额减少归因于于2026年1月30日公布并自2026年1月1日起追溯生效的中国新增值税法,改变了医药批发企业销售普通生物制品的税务处理方式。此乃由于集团无法将增加的增值税转嫁予最终客户,因为中国集中采购系统项下的包含增值税的售价是固定的,而营业额已扣除增值税。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657496335","title":"亿胜生物科技(01061)将于9月2日派发中期股息每股0.05港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657496335","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657496335?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:28","pubTimestamp":1785929292,"startTime":"0","endTime":"0","summary":"亿胜生物科技(01061)发布公告,将于2026年9月2日派发截至2026年6月30日止六个月中期股息每股0.05港元。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_40.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_40.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1476430.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4585","BK1161","BK4588","01061","VIG","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133544593","title":"亿胜生物科技2026年7月股份变动月报:回购350,000股并转为库存股","url":"https://stock-news.laohu8.com/highlight/detail?id=1133544593","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133544593?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:49","pubTimestamp":1785746963,"startTime":"0","endTime":"0","summary":"亿胜生物科技有限公司于2026年8月3日披露截至2026年7月31日的股份变动月报,报告显示当月完成350,000股股份购回并转为库存股,整体股本保持稳定。截至2026年7月31日,已发行股份由上月底的566,000,000股减少至565,650,000股;库存股份由1,006,000股增加至1,356,000股,总股份数维持在567,006,000股。本月购回股份于2026年7月2日进行,价格为HKD 2.5586,回购后即转为库存股份,暂无注销安排。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103573573","title":"亿胜生物科技(01061)8月5日举行董事会审议2026年中期业绩及派息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1103573573","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103573573?lang=zh_cn&edition=full","pubTime":"2026-07-24 17:05","pubTimestamp":1784883943,"startTime":"0","endTime":"0","summary":"亿胜生物科技有限公司(01061)7月24日发布公告称,公司董事会将于2026年8月5日(星期三)16:00在香港干诺道中168-200号信德中心西座3206室召开会议。\n本次会议议程包括:一、审阅并通过公司及其附属公司截至2026年6月30日止六个月的中期业绩;二、考虑派付中期股息(如有)。\n公告同时披露,公司执行董事为严名炽、方海洲、严贤龙及邱丽文;独立非执行董事为冯志英、邱梅美及甄文星。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652826906","title":"港股异动 | 亿胜生物科技(01061.HK)盈警后跌近13% 预期中期溢利同比减少约30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652826906","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652826906?lang=zh_cn&edition=full","pubTime":"2026-07-20 11:10","pubTimestamp":1784517035,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652269050","title":"港股异动 | 亿胜生物科技(01061)盈警后跌近13% 预期中期溢利同比减少约30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652269050","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652269050?lang=zh_cn&edition=full","pubTime":"2026-07-20 11:10","pubTimestamp":1784517035,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,亿胜生物科技(01061)盈警后跌近13%,截至发稿,跌12.89%,报2.5港元,报243.22万港元。消息面上,7月17日,亿胜生物科技发布公告,本集团预期截至2026年6月30日止六个月(2026年中期期间)收益及溢利较本集团2025年同期收益约8.77亿港元及溢利约1.63亿港元分别减少约10%及30%,主要是由于中国实施新增值税法后本集团承担的增值税增加所致。纵然存在上述情况,本集团仍维持稳健的现金流量及财务状况以满足其业务需求。于2026年6月30日,本集团的现金及现金等值物约为8.07亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","BK4585","BK4588","VXUS","01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652407220","title":"亿胜生物科技(01061)发盈警 预期中期溢利同比减少约30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652407220","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652407220?lang=zh_cn&edition=full","pubTime":"2026-07-17 19:08","pubTimestamp":1784286508,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿胜生物科技 发布公告,本集团预期截至2026年6月30日止六个月收益及溢利较本集团2025年同期收益约8.77亿港元及溢利约 1.63亿港元分别减少约10%及30%,主要是由于中国实施新增值税法后本集团承担的增值税增加所致。纵然存在上述情况,本集团仍维持稳健的现金流量及财务状况以满足其业务需求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469160.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"亿胜生物科技(01061)发盈警 预期中期溢利同比减少约30%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131926909","title":"亿胜生物科技(01061.HK)发盈利警告:上半年利润或同比降约30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131926909","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131926909?lang=zh_cn&edition=full","pubTime":"2026-07-17 19:05","pubTimestamp":1784286335,"startTime":"0","endTime":"0","summary":"亿胜生物科技有限公司7月17日在港交所公告披露,根据对截至2026年6月30日止六个月未经审计综合管理账目的初步审阅,公司预计期内收益及溢利将分别较2025年同期下降约10%及30%。2025年同期,公司实现收益约8.77亿港元,溢利约1.63亿港元。公司指出,业绩下滑主要受中国自2026年1月1日起追溯生效的新增值税法影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128696129","title":"亿胜生物科技回购35.00万股股份,总额约89.55万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128696129","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128696129?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:36","pubTimestamp":1782984983,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年7月2日发布翌日披露报表,公告当日在香港联交所回购股份的最新进展。本次公司于交易所场内回购35.00万股普通股,占本次事件前已发行股本约0.06184%,每股回购价介乎2.50港元至2.61港元,合计耗资约89.55万港元。公司确认上述回购事宜已按照香港联交所相关上市规则及 applicable 法律法规的规定进行,并获得董事会正式批准。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技回购35.00万股股份,总额约89.55万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648505678","title":"亿胜生物科技(01061)7月2日斥资89.55万港元回购35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648505678","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648505678?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:29","pubTimestamp":1782984582,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿胜生物科技(01061)发布公告,于2026年7月2日斥资89.55万港元回购35万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01061","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122430976","title":"亿胜生物科技更新2026年6月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1122430976","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122430976?lang=zh_cn&edition=full","pubTime":"2026-07-02 12:15","pubTimestamp":1782965746,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年7月2日发布截至2026年6月30日止当月的股份变动月报表。本月法定股本保持在10亿股,面值每股0.1港元,注册股本维持1亿港元,总股本结构与上月底相比无实质变化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166115195","title":"亿胜生物科技回购27.3万股,总额约72.52万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166115195","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166115195?lang=zh_cn&edition=full","pubTime":"2026-06-30 16:57","pubTimestamp":1782809840,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年6月30日发布公告,披露当日回购普通股27.3万股,占回购前公司已发行股本约0.04821%。本次回购价格区间介乎每股2.62港元至2.69港元,合计动用资金約72.52万港元。\n根据公告,回购完成后,公司已发行股本变动为5.66亿股,库藏股数量增至约100.6万股。公司回购授权于2026年5月26日通过,可回购最多5670.06万股。截至公告日,公司已根据该授权累计回购100.6万股,占授权通过时公司已发行股本约0.17742%。\n公司在公告中确认已遵守香港联交所上市规则及相关法例。上述公告由公司董事方海洲签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技回购27.3万股,总额约72.52万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187448652","title":"亿胜生物科技:6月29日回购1万股股份,耗资约2.71万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187448652","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187448652?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:55","pubTimestamp":1782723357,"startTime":"0","endTime":"0","summary":"亿胜生物科技有限公司公告称,于2026年6月29日通过香港联交所场内回购公司股份,共计1万股,占当日回购前公司已发行股本约0.00177%。每股回购价均为2.71港元,合计耗资约2.71万港元。根据公告,此次回购基于2026年5月26日股东大会通过的回购授权,该授权允许公司最多回购56,700,600股,公司已在本交易所或其他交易所累计回购733,000股。公司确认已遵守香港联交所相关上市规则及其他适用法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技:6月29日回购1万股股份,耗资约2.71万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322694","title":"亿胜生物科技(01061)6月29日斥资约2.71万港元回购1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322694","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647322694?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:51","pubTimestamp":1782723089,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿胜生物科技(01061)发布公告,于2026年6月29日该公司斥资约2.71万港元回购1万股,回购价格为每股2.71港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173535158","title":"亿胜生物科技6月26日回购5.00万股,涉资约13.50万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1173535158","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173535158?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:12","pubTimestamp":1782465163,"startTime":"0","endTime":"0","summary":"亿胜生物科技于2026年6月26日发布翌日披露报表公告。公告显示,公司于当日在香港联合交易所场内回购普通股5.00万股,占该次股份变动前已发行股份约0.00883%,每股回购价为港币2.70元,合计涉资约13.50万港元。本次回购完成后,公司已发行股本变更为5.66283亿股,库藏股增至72.3万股,合计仍为5.67006亿股。根据公告,回购授权由公司于2026年5月26日通过,授权总数为5670.06万股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技6月26日回购5.00万股,涉资约13.50万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646240358","title":"亿胜生物科技(01061)6月26日斥资约13.5万港元回购5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646240358","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646240358?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:09","pubTimestamp":1782464957,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿胜生物科技(01061)发布公告,于2026年6月26日该公司斥资约13.5万港元回购5万股,回购价格为每股2.70港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459394.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","01061"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144513015","title":"亿胜生物科技:6月25日回购10万股,耗资约26.35万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144513015","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144513015?lang=zh_cn&edition=full","pubTime":"2026-06-25 16:55","pubTimestamp":1782377743,"startTime":"0","endTime":"0","summary":"亿胜生物科技(股票代码:01061)于2026年6月25日公告,基于回购授权在香港联交所场内回购合计10万股普通股,占该次事件前已发行股本(不包括库藏股)约0.01765%。每股回购价介乎港币2.63元至2.64元,合计支付约26.35万港元。回购完成后,公司已发行股本(不包括库藏股)变更为5.66333亿股,库藏股数增至67.3万股。\n公司此前于2026年5月26日通过回购授权,总可回购股份数为5670.06万股。截至目前,公司已在交易所累积回购67.3万股,占授权通过日已发行股本的约0.11869%。公告同时确认已遵守相关上市规则与法例程序。\n本公告由公司董事方海洲签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿胜生物科技:6月25日回购10万股,耗资约26.35万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01061"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.essexbio.com","stockEarnings":[{"period":"1week","weight":-0.0464},{"period":"1month","weight":-0.1956},{"period":"3month","weight":-0.2264},{"period":"6month","weight":-0.4179},{"period":"1year","weight":-0.5197},{"period":"ytd","weight":-0.3577}],"compareEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":0.0974},{"period":"3month","weight":-0.0267},{"period":"6month","weight":-0.0243},{"period":"1year","weight":0.0407},{"period":"ytd","weight":0.0111}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"亿胜生物科技有限公司是一家主要从事生产及销售治疗体表创伤和眼部损伤生物药品的投资控股公司。该公司通过三个业务分部进行运营。外科分部主要从事开发、制造及销售贝复济液体制剂、贝复济冻干粉及贝复新凝胶以及其他产品。眼科分部从事开发、制造与销售贝复舒滴眼液、贝复舒眼用凝胶及贝复舒单剂量滴眼液以及其他产品。提供服务分部主要从事提供医疗科技电子平台相关医疗服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.733333,"avgChangeRate":0.036282},{"month":2,"riseRate":0.6,"avgChangeRate":0.051619},{"month":3,"riseRate":0.533333,"avgChangeRate":0.042805},{"month":4,"riseRate":0.466667,"avgChangeRate":0.031977},{"month":5,"riseRate":0.4,"avgChangeRate":-0.012005},{"month":6,"riseRate":0.4,"avgChangeRate":0.022498},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.030524},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.003954},{"month":9,"riseRate":0.533333,"avgChangeRate":0.03471},{"month":10,"riseRate":0.333333,"avgChangeRate":0.013996},{"month":11,"riseRate":0.466667,"avgChangeRate":0.008914},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.018984}],"exchange":"SEHK","name":"亿胜生物科技","nameEN":"ESSEX BIO-TECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亿胜生物科技(01061)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亿胜生物科技(01061)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亿胜生物科技,01061,亿胜生物科技股票,亿胜生物科技股票老虎,亿胜生物科技股票老虎国际,亿胜生物科技行情,亿胜生物科技股票行情,亿胜生物科技股价,亿胜生物科技股市,亿胜生物科技股票价格,亿胜生物科技股票交易,亿胜生物科技股票购买,亿胜生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亿胜生物科技(01061)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亿胜生物科技(01061)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}